SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15

M. Tessema, C. M. Yingling, C. L. Thomas, D. M. Klinge, A. M. Bernauer, Y. Liu, S. Dacic, J. M. Siegfried, S. E. Dahlberg, J. H. Schiller, S. A. Belinsky